ArticleJournal of neuro-oncology2018
Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data.
Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.
- Quality indicators in cranial neurosurgery: current insights and critical evaluation - a systematic review.Neurosurgical review · 2024Pooled it
- Readmission Following Extracranial-Intracranial Bypass Surgery: Risk Factors and Patient Characteristics Using the ACS NSQIP Database.Neurosurgery practice · 2026Article
- Factors Associated With Readmission to Index vs. Non-Index Hospitals After Major Cancer Surgery.Cancer medicine · 2025Article
- Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population.Journal of neuro-oncology · 2025Article
- Associations between central nervous system tumor diagnosis stage and survival and Medicaid enrollment among children, adolescents, and young adults.Neuro-oncology practice · 2025Article
- Optimizing patient outcome in intracranial tumor surgery: a detailed prospective study of adverse events and mortality reduction strategies in neurosurgery.Acta neurochirurgica · 2024Article
- RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients.Journal of neuro-oncology · 2023Article
- Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures.Journal of neuro-oncology · 2023Article
- An economic study of neuro-oncological patients in a large developing country: a cost analysis.Arquivos de neuro-psiquiatria · 2022Article
- Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Readmissions Database (NRD).Journal of neuro-oncology · 2022Article
- Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States.Scientific reports · 2021Article
- Early unplanned readmission of neurosurgical patients after treatment of intracranial lesions: a comparison between surgical and non-surgical intervention group.Acta neurochirurgica · 2020Article
- Increased 30-day readmission rate after craniotomy for tumor resection at safety net hospitals in small metropolitan areas.Journal of neuro-oncology · 2020Article
- Postpartum length of stay and risk for readmission among women with preeclampsia.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2020Article
- Readmission after neurosurgical intervention in epilepsy: A nationwide cohort analysis.Epilepsia · 2020Article
- Initial biopsy and early re-resection practices in the treatment of glioblastoma among AANS/CNS tumor section surgeons.Journal of neuro-oncology · 2019Article
- Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.World neurosurgery · 2019Article
- Readmission following inpatient stereotactic radiosurgery for brain tumors.Journal of radiosurgery and SBRT · 2019Article
- Predictors of Surgical Site Infection After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.World neurosurgery · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
Abstract
Hospital readmissions are a major contributor to increased health care costs and are associated with worse patient outcomes after neurosurgery. We used the newly released Nationwide Readmissions Database (NRD) to describe the association between patient, hospital and payer factors with 30- and 90-day readmission following craniotomy for malignant brain tumor. All adult inpatients undergoing craniotomy for primary and secondary malignant brain tumors in the NRD from 2013 to 2014 were included. We identified all cause readmissions within 30- and 90-days following craniotomy for tumor, excluding scheduled chemotherapeutic procedures. We used univariate and multivariate models to identify patient, hospital and administrative factors associated with readmission. We identified 27,717 admissions for brain tumor craniotomy in 2013-2014, with 3343 (13.2%) 30-day and 5271 (25.7%) 90-day readmissions. In multivariate analysis, patients with Medicaid and Medicare were more likely to be readmitted at 30- and 90-days compared to privately insured patients. Patients with two or more comorbidities were more likely to be readmitted at 30- and 90-days, and patients discharged to skilled nursing facilities or home health care were associated with increased 90-day readmission rates. Finally, hospital procedural volume above the 75th percentile was associated with decreased 90-day readmission rates. Patients treated at high volume hospitals are less likely to be readmitted at 90-days. Insurance type, non-routine discharge and patient comorbidities are predictors of postoperative non-scheduled readmission. Further studies may elucidate potentially modifiable risk factors when attempting to improve outcomes and reduce cost associated with brain tumor surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.